在一个后COVID病例中的Takotsubo心肌病
Amanpreet S Wasir1, Ravi Kalra1, Puneet Verma2
1Cardiology, Bharati Vidyapeeth University and Medical College, Pune, IND.
Cureus
|October 23, 2023
概括
塔科特苏博心肌病 (TTC),通常在绝经后的女性中见到,可以模仿心脏病发作. 这一案例突出显示了COVID-19后持续的透缩功能障碍,这表明病毒和TTC之间存在潜在的联系.
科学领域:
- 心脏病学 心脏病学
- 传染性疾病 传染性疾病
- 心血管医学 心血管医学
背景情况:
- 塔科茨博心肌病 (TTC) 与急性冠状动脉综合征类似,主要影响绝经后妇女.
- 最近的研究表明,在COVID-19大流行期间,TTC病例有所增加,可能与病毒引起的压力和catecholamine激增有关.
- 虽然TTC通常会消失,但可能会出现持续的功能障碍,特别是在COVID-19后的情景中.
研究的目的:
- 为了记录一个Takotsubo心肌病病例的特征和结果.
- 探索COVID-19心肌炎对TTC患者心脏功能潜在的残留影响.
- 调查COVID-19和TTC日益流行之间的可能关联.
主要方法:
- 病例报告详细介绍了TTC患者的临床表现,诊断结果和随访情况.
- 在COVID-19大流行期间对TTC流行情况的最新文献的审查.
- 对心脏功能进行分析,重点关注心缩和心缩参数.
主要成果:
- 该病例呈现了典型的TTC特征,但在COVID-19后显示了持续的,恶化的透缩功能障碍.
- 这种持续的功能障碍可能代表剩余的COVID-19心肌炎,而不是典型的TTC解决方案.
- 建议TTC和COVID-19感染之间存在潜在的独立关联.
结论:
- 在COVID-19大流行期间,Takotsubo心肌病病例正在增加.
- 在COVID-19后的持续扩张性功能障碍中,TTC需要进一步调查COVID-19心肌炎.
- 需要更多的临床证据来确认COVID-19和Takotsubo心肌病之间的直接关系.
更多相关视频
14:35Post-Myocardial Infarction Heart Failure in Closed-chest Coronary Occlusion/Reperfusion Model in Göttingen Minipigs and Landrace Pigs
Published on: April 17, 2021
8.5K
12:45Benefits of Cardiac Resynchronization Therapy in an Asynchronous Heart Failure Model Induced by Left Bundle Branch Ablation and Rapid Pacing
Published on: December 11, 2017
10.5K
相关概念视频
01:14Myocarditis III: Medical Management
7
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
7
01:30Cardiomyopathy II: Dilated Cardiomyopathy
11
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
11
01:29Cardiomyopathy IV: Restrictive Cardiomyopathy
12
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
12
01:29Cardiomyopathy III: Hypertrophic Cardiomyopathy
16
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
16
01:19Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
19
The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
19
01:25Cardiomyopathy I: Introduction and Classification
14
Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
14